See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 15, 2006

Healthy Patient Studies Shingles Lymphocytic Leukemia, Acute

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Healthy Patient Studies

The Pfizer Ann Arbor Clinical Research Unit is seeking healthy men and women, ages 18 to 55, to participate in investigational drug studies. To be eligible for most studies, you must: be drug free, have no chronic illnesses, have no history of a severe allergic reaction, and smoke no more than five cigarettes per day. Studies will require a stay of 10-20 consecutive nights at the clinic, with additional outpatient visits. Payment for completion of a study begins at $2,200.

The research site is in Ann Arbor, Mich.

More information

Please see



Are you still in pain even though your shingles have healed? This research study will evaluate an investigational medication for the treatment of post-shingles pain (post herpetic neuralgia). Participants will receive study medication and examinations, and reimbursement for time and travel.

The research site is in Tucson, Ariz.

More information

Please see


Lymphocytic Leukemia, Acute

This is a phase II study of campath-1H in children with acute lymphoblastic leukemia. Candidates must be 21 or younger with acute lymphoblastic leukemia that has either relapsed despite two or more uses of other treatments, or the cancer has failed to go into remission despite two or more attempts with other treatments.

The research site is in Cincinnati, Ohio.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.